Direct inhibitory effect on viral entry of influenza A and SARS‐CoV‐2 viruses by azithromycin

OBJECTIVES: Using strategy of drug repurposing, antiviral agents against influenza A virus (IAV) and newly emerging SARS‐coronavirus 2 (SARS‐CoV‐2, also as 2019‐nCoV) could be quickly screened out. MATERIALS AND METHODS: A previously reported engineered replication‐competent PR8 strain carrying luci...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xiaohong, Zuo, Xiangyang, Meng, Fang, Han, Chenfeng, Ouyang, Wei, Han, Yu, Gu, Yayun, Zhao, Xin, Xu, Feng, Qin, Frank Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744835/
https://www.ncbi.nlm.nih.gov/pubmed/33211371
http://dx.doi.org/10.1111/cpr.12953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744835/
https://www.ncbi.nlm.nih.gov/pubmed/33211371
http://dx.doi.org/10.1111/cpr.12953

Ejemplares similares